Search Results
10
Everything
Search Filters
Tag
Health Canada
Kane Biotech Announces Canadian Distribution Agreement With Best Buy Medical for revyve™ Antimicrobial Wound Gel
March 11, 2025 08:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 11, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (“Kane Biotech”) announces that it has concluded a three-year distribution agreement with Best Buy...
CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
February 26, 2025 07:00 ET
|
CytoSorbents
CytoSorbents Announces Fourth Quarter and Full Year 2024 Earnings Release Date for March 6, 2025
CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants
February 25, 2025 07:00 ET
|
CytoSorbents
CytoSorbents Strengthens Balance Sheet with Additional $1.6M in Aggregate Gross Proceeds from Shareholder Exercise of Series A Right Warrant
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue
January 03, 2025 07:00 ET
|
CytoSorbents
CytoSorbents' Preliminary Unaudited Q4 2024 Product Revenue Increased 22-25% From A Year Ago With Product Gross Margins Of ~70%
Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary Supplement
December 11, 2024 12:47 ET
|
Nufarm
Nutriterra® Total Omega-3 Receives Health Canada Approval as Plant-Based Dietary Supplement. This groundbreaking ingredient delivers DHA through canola.
Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel
November 14, 2024 13:10 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its...
CytoSorbents Reports Third Quarter 2024 Financial and Operational Results
November 07, 2024 16:05 ET
|
CytoSorbents
PRINCETON, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
bioLytical Laboratories Inc. Announces Health Canada Authorization of its rapid INSTI® HCV Antibody Test for Professional Use in Canada
November 04, 2024 12:00 ET
|
bioLytical Laboratories Inc.
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Canadian market
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
November 04, 2024 07:00 ET
|
CytoSorbents
CytoSorbents submits DrugSorb-ATR Medical Device License Application to Health Canada following MDSAP Certification. Expects regulatory decision in 2025
Quality Smart Solutions Launches GRAS Experts to Protect Against Food Safety Risks
October 25, 2024 12:24 ET
|
Quality Smart Solutions Inc.
TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- In light of McDonald’s recent recall of Quarter Pounders due to E. coli contamination, the need for stringent oversight on food ingredients has never been...